Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – C-o-group doai
Reexamination Certificate
2005-02-17
2009-10-20
Landsman, Robert (Department: 1647)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
C-o-group doai
C514S168000, C514S821000
Reexamination Certificate
active
07605185
ABSTRACT:
A polypeptide is identified as being functionally included in a signal transduction pathway having a biological effect. Contemplated polypeptides are different from a retinoic acid receptor, a retinoid X receptor, or a cellular retinoic acid binding protein, however bind a retinoid or retinoid metabolite, and binding of the retinoid or retinoid metabolite lead to a modulation of the biological effect. In particularly contemplated methods, a retinoid or retinoid metabolite is administered to a cell or mammal in a concentration effective to modulate the biological effect.
REFERENCES:
patent: 5124313 (1992-06-01), Schaeffer et al.
patent: 5968981 (1999-10-01), Chien et al.
patent: 6221618 (2001-04-01), Chien et al.
patent: 6358697 (2002-03-01), Rothenberg et al.
Armstrong et al., 13-cis retinoic acid and isomerization in paediatric oncology is changing shape the key to success?, 2005, Biochemical Pharmacology, vol. 69, pp. 1299-1306.
Gottardis et al., The efficacy of 9-cis retinoic acid in experimental models of cancer, 1996, Breast Cancer Research and Treatment, vol. 38, pp. 85-96.
Giguere, Vincent, “Retinoic Acid Receptors and Cellular Retinoid Binding Proteins: Complex Interplay in Retinoid Signaling”, J. Endocrine Society, Aug. 1994, pp. 61-79, vol. 15, No. 1, USA.
Kuno, Shin-Ichi et al., “Outgrowth of pseudopodial cables induced by all-trans retinoic acid in micromere-derived cells isolated from sea urchin embryos”, Develop. Growth Differ., 1999, pp. 193-199, vol. 41, Japan.
Allikmets, Rando et al., “A photoreceptor cell-specific ATP-binding transporter gene (ABCR) is mutated in recessive Stargardt macular dystrophy”, Nature Genetics, Mar. 1997, pp. 236-246, vol. 15.
James, Thomas N., M.D., “Normal and Abnormal Consequences of Apoptosis in the Human Heart From Postnatal Morphogenesis to Paroxysmal Arrhythmias”, Circulation, Jul. 1994, pp. 556-573, vol. 90, No. 1, Texas, USA.
Decottignies, Anabelle et al., “Complete Inventory of the yeast ABC proteins”, Nature Genetics, Feb. 1997, pp. 137-145, vol. 15.
Lee, K. et al., “Ciclazindol Inhibits ATP-Sensitive K+ Channels and Stimulates Insulin Secretion in CRI-G1 Insulin-Secreting Cells”, Molecular Pharmacology, 1996, pp. 715-720, vol. 49,USA.
Demolombe, Sophie et al., “ATP-binding cassette proteins as targets for drug discovery”, TiPS, Aug. 1996, pp. 273-275, vol. 17, USA.
Ämmälä, Carina et al., “Promiscuous coupling between the sulphonylurea receptor and inwardly rectifying potassium channels”, Feb. 8, 1996, pp. 545-548, vol. 379, USA.
Kolaczkowski, Marcin et al., “Anticancer Drugs, Ionophoric Peptides, and Steroids as Substrates of the Yeast Multidrug Transporter Pdr5p”, The Journal of Biological Chemistry, Dec. 6, 1996, pp. 31543-31548, vol. 271, No. 49, USA.
Notsu, T. et al., “Block of ATP Regulated K+ Channels by Sodium 5-Hydroxydecanoate, A new Antiarrhythmic Agent, In Isolated Guinea-Pig Heart Cells”, J. Mol Cell Cardiol., 1989, pp. S.9, Supplement II, Abstract 27, USA.
Luciani, Marie-Francoise et al., “The ATP binding cassette transporter ABC1, is required for the engulfment of corpses generated by apoplotic cell death”. The EMBO Journal, 1996, pp. 226-235, vol. 15, No. 2, USA.
Kralli, Anastasia et al., “An FK506-sensitive Transporter Selectively Decreases Intracellular Levels and Potency of Steroid Hormones”, The Journal of Biological Chemistry, Jul. 19, 1996, pp. 17152-17156, vol. 271, No. 29, USA.
Abbott, Geoffrey W. et al., “MiRP1 Forms Ikr Potassium Channels with HERG and Is Associated with Cardiac Arrhythmia”, Cell Press, Apr. 16, 1999, pp. 175-187, vol. 97, USA.
Tucker, Stephen J. et al., “Truncation of Kir6.2 produces ATP-sensitive K+ channels in the absence of the sulphonylurea receptor”, Nature, May 8, 1997, pp. 179-183, vol. 387, USA.
Gribble, Fiona M. et al., “Tissue Specificity of Sulfonylureas—Studies on Cloned Carida and •-Cell KATP Channels”, Diabetes, Sep. 1998, pp. 1412-1418, vol. 47, USA.
Zona, Cristina et al., “Arachidonic acid augments potassium currents in rat neocortical neurones”, Molecular Neuroscience, Apr. 1993, pp. 359-362, vol. 4, No. 4, USA.
Smith-Thomas, Linda et al., “Effects of Isotretinoin on the Behavior of Neural Crest Cells in Vitro”, Brief Notes, 1987, pp. 276-281; USA.
Lu, Xian-Ping et al., “Novel retinoid-related molecules as a apoptosis inducers and effective inhibitors of human lung cancer cells in vivo”, Nature Medicine, Jun. 1997, pp. 686-690, vol. 3, USA.
Janick-Buckner, D. et al., “Induction of HL-60 cell differentiation by water-soluable and nitrogen-containing conjugates of retinoic acid and retinol”, The FASEB Journal, Mar. 1991, pp. 320-325, vol. 5, USA.
Bissonnette, Reid P. et al., “9-cis Retinoic Acid Inhibition of Activation-Induced Apoptosis Is Mediated via Regulation of Fas Ligand Requires Retinoic Acid Receptor and Retinoid X Receptor Activation”, Molecular and Cellular Biology, Oct. 1995, pp. 5576-5585, vol. 15, No. 10, USA.
Wang, Xin et al., “Retinoic acid up-regulates ciliary neurotrophic factor receptors in cultured chick neurons and cariomyocytes”, Neuroscience Letters, 1998, pp. 9-12, USA.
Kitabayashi, Issay et al., “A Novel Pathway For Retinoic Acid-Induced Differentiation of F9 Cells That Is Distinct From Receptor-Medciated Trans-Activation”, In Vitro Cell Dev. Bio., Nov. 1994, pp. 761-768, USA.
Davis, W.L. et al., “Changes in cytosolic calcium, bleb formation, and cell death in neural crest cells treated with isotretinoin and 4-oxo-isotretinoin”, Abstract—Journal of Craniofacial Genetics & Developmental Biology, Apr.-Jun. 1991, pp. 105-118, vol. 11, No. 2, USA.
Willnow, Thomas E. et al., “Lipoprotein receptors: new roles for ancient proteins”, Nature Cell Biology, Oct. 1999, pp. E157-E162, vol. 1, USA.
Davis, Faith B. et al., “Retinoic Acid Inhibits Calmodulin Binding to Human Erythrocyte Membranes and Reduces Membrane CA2+-Adenosine Triphosphatase Activity”, J. Clin. Invest., Jun. 1990, pp. 1999-2003, vol. 85, USA.
Vakiani, Efsevia et al., “Substrate Specificity and Kinetic Mechanism of the Insect Sulfotransferase, Retinol Dehydratase”, The Journal of Biological Chemistry, Dec. 25, 1998, pp. 35381-35387, vol. 273, No. 52, USA.
Dousa, Thomas P. et al., “Modulation of renal Na-Pi cotransport by hormones acting via genomic mechanism and by metabolic factors”, Kinney International, 1996, pp. 997-1004, vol. 49, USA.
Shao, Zhi-Ming et al., “p53 independent G0/G1 arrest and apoptosis induced by a novel retinoid in human breast cancer cells”, Oncogene, 1995, pp. 493-504, vol. 11, USA.
Guo, Yuan et al., “All-trans retinol, vitamin D and other hydrophobic compounds bind in the axial pore of the five-stranded coiled-coil domain of cartilage oligomeric matrix protein”, The EMBO Journal, 1998, pp. 5265-5272, vol. 17, No. 18, USA.
Pijnappel, W. W. M. et al., “The retinoid ligand 4-oxo-retinoic acid is a highly active modulator of positional specification”, Nature, Nov. 1993, pp. 340-344, vol. 366, USA.
Kang, Jing X. et al., “Protective Effects of All-Trans-Retinoic Acid Against Cardiac Arrhythmias Induced by Isoproterenol, Lysophosphatidylcholine or Ischemia and Reperfusion”, Journal of Cardiovascular Pharmacology, 1995, pp. 943-948, vol. 26, No. 6, USA.
Zhou, Ming Dong et al., “Retinoid-dependent pathways suppress myocardial cell hypertrophy”, Proc. Natl. Acad. Sci., Aug. 1995, pp. 7391-7395, vol. 92, USA.
Abbott, Barbara D. et al., “Retinoic acid alters epithelial differentiation during palatogenesis”, J. Craniofac Genet Dev. Bio., 1991, pp. 315-325, USA.
Lammer, Edward, “Preliminary observations on isotretinoin-induced ear malformations and pattern formation of the ex
Dang Ian
Fitch Even Tabin & Flannery
Landsman Robert
LandOfFree
Treatment of arrhythmia by retinoids affecting signal... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Treatment of arrhythmia by retinoids affecting signal..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Treatment of arrhythmia by retinoids affecting signal... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4132201